Direct factory supply with HPLC/LC-MS chromatographic purity verification, complete batch traceability, and rapid 3–5 day dispatch from 1 kg MOQ.
Next-generation direct retinoic acid receptor binder offering potent anti-aging gene expression without causing standard epidermal irritation.
Supercritical CO2 extract standardized in pungent bio-active gingerols, delivering verifiable antioxidant, anti-inflammatory, and digestive support.
Highly purified triterpenoid sapogenin derived from Astragalus membranaceus root, engineered specifically for premium longevity and cellular rejuvenation formulas.
Standardized biochanin A, formononetin, daidzein, and genistein profile formulated for women's hormonal balance and cardiovascular nutraceutical blends.
Pure microbial fermented amino acid indispensable for intestinal mucosal repair, muscle catabolism prevention, and performance clinical nutrition.
Purified structural glucan polysaccharide acting on macrophage Dectin-1 receptors to trigger innate immune surveillance without inflammatory rebound.
Standardized isothiocyanate produced by myrosinase enzymolysis, representing nature's most potent endogenous phase-II enzyme and antioxidant inducer.
Pharmaceutical-grade, low-residual-acid nicotinamide specifically synthesized for dermal barrier reinforcement, ceramides synthesis, and hyperpigmentation clearing.
Gavra Bio-Tech Co.,Ltd. establishes unmatched quality assurance by integrating GAP-certified agricultural provenance, industrial continuous extraction, and chromatography validation.
Raw material safety begins in the soil. We operate over 500 acres of experimental cultivation fields in Henan, China, implementing Good Agricultural and Collection Practices (GACP). Every botanical batch carries transparent cultivar records, pesticide monitoring logs, and meteorological tracking to guarantee low-heavy-metal biomass before processing.
Our manufacturing core is an 8,000 m² Class D GMP cleanroom facility running 3 specialized extraction and purification trains. Featuring continuous countercurrent extractors, vacuum thin-film evaporators, resin columns, and high-capacity spray-drying towers, we transform over 3,000 metric tons of raw botanical material annually.
Expanding beyond bulk raw powders, our contract processing department provides full contract formulation services. We engineer functional pectin/gelatin gummies, two-piece hard-shell capsules, effervescent tablets, and micro-encapsulated water-dispersible emulsions aligned with strict private-label client specifications.
To protect global brands against botanical adulteration, misidentification, and synthetic spiking, our in-house testing center is staffed with Ph.D. analytical chemists executing batch-specific molecular release assays.
Provides precise molecular mass confirmation, isotopic fragment identification, and ultra-trace level impurity profiling down to parts-per-billion (ppb) thresholds for peptides and specialized sapogenins.
Executes quantitative optical density assays and multi-wavelength absorption scans to monitor total polyphenol, flavonoid, and polysaccharide titrations across bulk botanical production lots.
Delivers standardized high-performance thin-layer chromatographic botanical fingerprinting, ensuring unequivocal plant species authentication against certified compendial reference standards.
Global supply chains are undergoing a paradigm shift driven by stringent regulatory frameworks, analytical scrutiny, and conscious consumer expectations.
For decades, commercial procurement contracts relied on legacy extraction ratios such as "10:1" or "20:1". These metrics are inherently ambiguous, susceptible to adulteration with maltodextrin carriers, and fail to provide quantifiable pharmacological activity. Forward-looking procurement directors in North America, Europe, and Japan are mandating chemically standardized active markers verified via validated reverse-phase High-Performance Liquid Chromatography (RP-HPLC) or Ultra-Performance Liquid Chromatography (UPLC).
Standardized specifications—such as isolating 98% Cycloastragenol, 20% Total Gingerols, or 40% Isoflavones—allow contract formulators to calculate precise clinical dosages. Gavra Bio-Tech guarantees exact chromatographic assay thresholds backed by third-party inter-laboratory validation to support health claim documentation under EFSA and US FDA dietary supplement regulations.
Environmental legislation and clean-label cosmetic formulations are rapidly phasing out toxic Class 2 organic solvents, including hexane, dichloromethane, and ethyl acetate. Strategic procurement teams are actively switching supply agreements to factories deploying Supercritical CO2 (scCO2) extraction, Subcritical Water extraction (SWE), and bio-enzymatic cellular breakdown.
By utilizing supercritical carbon dioxide operating above its critical temperature and pressure, our extraction facilities isolate heat-sensitive lipids, terpenes, and gingerols without thermal degradation. The resulting extract requires zero secondary heat solvent stripping, preserves volatile aromatics, and leaves absolute zero residual chemical solvents, complying effortlessly with USP <467> and European Pharmacopoeia (Ph. Eur.) Class 3 guidelines.
Adulteration in botanical raw materials—whether through intentional economic adulteration with cheaper lookalike biomass or accidental cross-species contamination during harvesting—represents a catastrophic recall risk for consumer brands. Leading international ingredient buyers now require suppliers to prove raw material authenticity at the molecular taxonomic level.
Exploring cutting-edge molecular delivery matrices, biotransformation pathways, and industrial scaling technologies deployed at Gavra Bio-Tech.
Many of the most potent natural actives (e.g., Cycloastragenol, Sulforaphane, HPR) suffer from inherently low water solubility and poor oral or transdermal bioavailability. We have industrialized specialized phospholipid liposomal encapsulation and Self-Microemulsifying Drug Delivery Systems (SMEDDS). These sub-micron colloidal carriers shield bioactives from gastric enzymatic degradation and enhance cellular uptake kinetics up to 800% compared to native crystalline powders.
Traditional plant extraction is physically limited by the plant's native secondary metabolite concentrations. Gavra Bio-Tech harnesses enzymatic deglycosylation and microbial fermentation to cleave inactive sugar moieties from botanical glycosides, yielding pure, bioavailable aglycone metabolites. For instance, our proprietary myrosinase activation process converts glucoraphanin into pure bioactive Sulforaphane with optimized thermodynamic stability.
To scale molecules like 99% Hydroxypinacolone Retinoate and 98% Cycloastragenol without generating hazardous solvent waste, we utilize Simulated Moving Bed (SMB) continuous chromatography. This continuous countercurrent operational mode reduces stationary phase consumption by 60% and solvent volume by 70%, allowing us to provide high-purity single-isolate compounds at competitive global wholesale price points.
Clear technical, commercial, and regulatory answers addressing common friction points in international plant extract procurement.
Connect with our senior phytochemical formulation engineers. We evaluate your target specifications, calculate wholesale volume price brackets, and dispatch verified 10 g–100 g pilot samples to your laboratory within 48 hours.